U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Development Status
Other
65
US Approved Rx
6
Investigational
4
Possibly Marketed Outside US
4
US Approved Allergenic Extract
4
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Primary Target
NADH-cytochrome b5 reductase 3
2
Nitric oxide synthase (inducible and endothelial)
2
Apoptosis
1
Oxidoreductases
1
P2X purinoceptor 2
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Highest Phase
Approved
5
Phase III
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
Unknown
70
1921
2
1941
2
1972
2
2010
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Condition
Alzheimer’s disease
2
Cancer
2
Dermatologic infections
2
Ifosfamide-induced encelophaty
2
Methemoglobinemia
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Treatment Modality
Diagnostic
4
Primary
3
Preventing
2
Inactive ingredient
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
CNS Activity
CNS Penetrant
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Originator
BASF
2
Ehrlich, P.
1
Eisai Co., Ltd.
1
Mihalik, B.
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Mixture
29
Structurally Diverse
28
Chemical
24
Nucleic Acid
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
FDA UNII
83
CAS
24
PUBCHEM
21
EPA CompTox
15
DAILYMED
13
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 1
VARIOUS
2
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 2
ALL OTHER THERAPEUTIC PRODUCTS
2
DIAGNOSTIC AGENTS
2
ANTINEOPLASTIC AGENTS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 3
ALL OTHER THERAPEUTIC PRODUCTS
2
OTHER DIAGNOSTIC AGENTS
2
OTHER ANTINEOPLASTIC AGENTS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 4
Antidotes
2
Tests for gastric secretion
2
Other antineoplastic agents
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
78
Salts, Hydrates, Esters, etc.
5
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Search results for
methylene root_notes_note
in
Note
(approximate match)
Showing
81 - 83
of
83
results
Search within data set
First page
Previous page
1
2
6
7
8
9
Next page disabled
Next page disabled
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
(+)-β-Turmerone
MORE DETAILS
JJN48395TB
Export Data
Search for Structure
Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)
(6R)-2-Methyl-6-[(1R)-4-methylene-2-cyclohexen-1-yl]-2-hepten-4-one
MORE DETAILS
7YB46T2WS9
Export Data
Search for Structure
Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)
CEPADACURSEN SODIUM
MORE DETAILS
H31ZZO36P5
Export Data
Sequence Search
Status:
Investigational
Class:
NUCLEIC ACID
Showing
81 - 83
of
83
results
Search within data set
First page
Previous page
1
2
6
7
8
9
Next page disabled
Next page disabled